AC IMMUNE SA's ticker is ACIU and the CUSIP is H00263105. A total of 36 filers reported holding AC IMMUNE SA in Q2 2022. The put-call ratio across all filers is 1.24 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,480,000 | – | 410 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 7,455,534 | $37,650,000 | 4.22% |
| Prosight Management, LP | 710,541 | $3,588,000 | 1.57% |
| Opus Point Partners Management, LLC | 39,801 | $201,000 | 0.27% |
| PA Capital LLC | 40,055 | $202,000 | 0.21% |
| Artal Group S.A. | 1,000,000 | $5,050,000 | 0.21% |
| Duquesne Family Office | 1,324,935 | $6,691,000 | 0.19% |
| Temasek Holdings (Private) Ltd | 2,614,095 | $13,201,000 | 0.09% |
| COHEN LAWRENCE B | 13,350 | $67,000 | 0.05% |
| BOOTHBAY FUND MANAGEMENT, LLC | 94,466 | $477,000 | 0.05% |
| Tekla Capital Management LLC | 171,813 | $868,000 | 0.04% |